To celebrate 40 years, the Certification Board of Infection Control and Epidemiology wants to showcase the certification milestones on their website.
Certification in infection control (CIC) is highly regarded certification in the infection prevention and control field, and the exam is developed by the Certification Board of Infection Control and Epidemiology, Inc, (CBIC). Recently, the 2023 president of CBIC, Elaine Larson, PhD, RN, CIC, LTC-CIP, FAAN, FAPIC, Columbia University School of Nursing, Bridgeport, Connecticut, spoke with Infection Control Today® (ICT®) about the CBIC’s strategic plan.
Additionally, as CBIC marks its 40th anniversary this year, CBIC wants to showcase certificants who have achieved certification milestones on their website. If you have been certified for 5 or more years, you can fill out the CBIC Milestone form to be featured. She will also presenting the CBIC Overview Panel Discussion at the Association for Professionals in Infection Control and Epidemiology (APIC) 2023 Annual Conference and Exhibition, held in Orlando, Florida, June 26 to 28, 2023. She and other presenters will have a panel discussion on initially and maintaining CBIC certifications and the future of CBIC certification.
“The certification board for infection control, epidemiology has been around…for 40 years,” Larson told ICT. “The idea is to provide infection prevention and control professionals, both infection preventionist, but also microbiologists, physicians, anybody who's interested in showing that they have developed and have possessed the core competencies that are necessary to run and to begin an infection prevention practice. It's a way to demonstrate your competence in your field. Many of the advantages are…a valid and reliable way to show other people, your peers, administrators that you have the basic core competencies for practicing in your field.”
ICT asked Larson about any updates with CBIC. “Our mission hasn't changed. Our mission is to provide pathways to demonstrate and maintain competence in infection prevention and control. So that's our mission to demonstrate and maintain confidence. But our new priorities are building on what we're already doing….We want to expand accessibility to certification for a variety of people across settings. We have the Associate Program certification [a-IPC]. Now, we also have the long-term care [exam]. We're looking at other sites such as ambulatory care and global health, and thinking about the importance of having the core competencies.
Larson also explained that infection is global, and CBIC needs to be relevant globally. “Every country has their different cultures, and the culture does change these things. But we want [to find] ways to have support for people from areas that can't afford it.”
She also explained the 3 priorities for CBIC, and that “in organizations where there are high numbers where the professionals are certified, they're more likely to have best practices. So we're always asking ourselves, How can we show whether what we're doing has an impact on patient outcomes? That is a challenge. But it's one we keep in mind all the time.”
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.